Greenphire CEO, Jim Murphy, Named to PharmaVoice 100
KING OF PRUSSIA, Pa., Sept. 19, 2023 /PRNewswire/ -- Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, announced that its Chief Executive Officer, Jim Murphy, has been named to the PharmaVoice 100 list, which recognizes pioneers at the forefront of the life sciences industry.
- Since joining Greenphire in 2015, Jim has transformed the company from a young startup to today's market leader.
- "It's an honor to be named to the PharmaVoice 100, especially alongside such remarkable industry leaders who are shaping the future of medical innovation," said Murphy.
- The PharmaVoice 100 celebrates pioneers in the field of life sciences who are leading the way in industry trends.
- To see the full list of PharmaVoice 100 honorees, visit: https://www.pharmavoice.com/topic/pharmavoice-100/